Periodic Reporting for period 1 - BEAMER (BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe)
Berichtszeitraum: 2021-09-01 bis 2022-08-31
On average 25%, of patients are non-adherent to prevention activities and disease management activities including medication intake, appointment scheduling, screening, exercise, and dietary changes. Some estimates show that nearly 50% of patients fail to adhere to treatment recommendations. When preventive or treatment regimens are complex and/or require lifestyle changes and modification of existing habits, non-adherence can be as high as 70%.
Medication non-adherence has been identified as a major barrier to effectively manage chronic conditions, leading to poorer health outcomes among patients, higher rates of hospitalization, and increased mortality. In fact, each year, as many as 125.000 premature deaths in the US and 200.000 in the EU are related to non-adherence, which causes personal suffering and significant cost burden on healthcare systems.
As a consequence, this eventually causes additional financial burden on healthcare systems and overall societal cost.
The EU-funded BEAMER project aims to collate the factors affecting non-adherence, including behavioural factors, into a computational model which can provide a solid foundation for understanding the problem and, hence, improve the effectiveness of future solutions. The aim of the model is to identify the actionable factors driving adherence and the enable the segmentation of the population based on specific needs for better targeting of support to the individual patient.
Furthermore, we have mapped out the existing data sources on these factors, and where we found gaps that needed to be surpassed, we designed data collection methodologies.
Finally, by knowing where our focus lied, based upon the prioritisation done at the first stages of the project as a result of the literature review and the Delphi consensus, we have been able to lay out the main conceptual framework of the model.
BEAMER will optimize the disease-agnostic adherence model by real-life testing proof-of-concept in 18 different pilots in Norway, Spain, the Netherlands, Germany, Portugal, and Italy, including over 18,000 patients (3000 patients in each thematic area). BEAMER will be embodied in an open source European searchable database, continuously updated, validated and optimized by empirical evidence and new insights, available to all stakeholders and adaptable for future developments in healthcare. Finally, extensive efforts will be directed to develop and implement dissemination and communication activities that increase exploitation and sustainability of BEAMER.
The impact of the model implementation is hopefully the reform of the way healthcare is provided. By putting the patient at the core of its system, we aim to deliver high-value personalised care, increase the adherence of patients to therapy, and lead to a significant decrease in healthcare costs across Europe.